Evidence mapPaperPMID 42409825Full record

ReviewNature communications2026

Engineering in vitro models to replicate the complexity of chronic wounds.

Lucas Argandoña, Kristina Ivanova, Tzanko Tzanov

Abstract readReview
In one paragraph

Review in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lucas ArgandoñaGrup de Biotecnologia Molecular i Industrial, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya (UPC-BarcelonaTech), Terrassa, Spain.ORCID 0009-0007-8816-9888
Kristina IvanovaGrup de Biotecnologia Molecular i Industrial, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya (UPC-BarcelonaTech), Terrassa, Spain.ORCID 0000-0001-9158-4088
Tzanko TzanovGrup de Biotecnologia Molecular i Industrial, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya (UPC-BarcelonaTech), Terrassa, Spain. tzanko.tzanov@upc.edu.ORCID 0000-0002-8568-1110

Funding

Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PID2022- 42229OB-I00
6 · The paper itself

Abstract

Chronic wounds represent a major clinical challenge driven by sustained inflammation, proteolytic imbalance, microbial colonisation, and impaired tissue regeneration. This review critically examines 2D and 3D in vitro models used in chronic wound research, evaluating their capacity to recapitulate chronicity across venous leg ulcers, diabetic foot ulcers, and pressure ulcers. Current systems lack the biochemical complexity required to reproduce key features of the non-healing phenotype. Building on quantitative clinical wound exudate data, we propose a feature-driven, aetiology-stratified framework that provides modular design considerations for in vitro models and chronic wound simulating media.

Indexed as

Models, BiologicalTissue EngineeringWound HealingAnimalsChronic DiseaseDiabetic FootHumansPressure UlcerVaricose Ulcer

Identifiers

PMID42409825
PMCPMC13372816

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.